These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 11918288

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential translation and fragile X syndrome.
    Vanderklish PW, Edelman GM.
    Genes Brain Behav; 2005 Aug; 4(6):360-84. PubMed ID: 16098135
    [Abstract] [Full Text] [Related]

  • 24. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM, Alekseyenko O, Serysheva E, Yuva-Paylor LA, Paylor R.
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [Abstract] [Full Text] [Related]

  • 25. A fragile balance: FMR1 expression levels.
    Oostra BA, Willemsen R.
    Hum Mol Genet; 2003 Oct 15; 12 Spec No 2():R249-57. PubMed ID: 12952862
    [Abstract] [Full Text] [Related]

  • 26. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
    Frankland PW, Wang Y, Rosner B, Shimizu T, Balleine BW, Dykens EM, Ornitz EM, Silva AJ.
    Mol Psychiatry; 2004 Apr 15; 9(4):417-25. PubMed ID: 14981523
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.
    Gruss M, Braun K.
    Neurochem Int; 2004 Jul 15; 45(1):81-8. PubMed ID: 15082225
    [Abstract] [Full Text] [Related]

  • 29. Dendritic spine structural anomalies in fragile-X mental retardation syndrome.
    Irwin SA, Galvez R, Greenough WT.
    Cereb Cortex; 2000 Oct 15; 10(10):1038-44. PubMed ID: 11007554
    [Abstract] [Full Text] [Related]

  • 30. Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.
    Kaufmann WE, Cohen S, Sun HT, Ho G.
    Microsc Res Tech; 2002 May 01; 57(3):135-44. PubMed ID: 12112448
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fragile X mental retardation: misregulation of protein synthesis in the developing brain?
    Feng Y.
    Microsc Res Tech; 2002 May 01; 57(3):145-7. PubMed ID: 12112449
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome.
    Galvez R, Gopal AR, Greenough WT.
    Brain Res; 2003 May 02; 971(1):83-9. PubMed ID: 12691840
    [Abstract] [Full Text] [Related]

  • 37. [Experimental therapeutic models for fragile X syndrome].
    de Diego-Otero Y.
    Rev Neurol; 2001 Oct 02; 33 Suppl 1():S70-6. PubMed ID: 12447824
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prospects for gene therapy in the fragile X syndrome.
    Rattazzi MC, LaFauci G, Brown WT.
    Ment Retard Dev Disabil Res Rev; 2004 Oct 02; 10(1):75-81. PubMed ID: 14994292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.